STUDY OBJECTIVES: Sodium bicarbonate ringer's solution is a novel crystalloid fluid that can effectively replenish circulating blood volume, improve renal blood perfusion, and maintain the body's acid-base homeostasis. The objective of this study was to compare the effects of sodium bicarbonate ringer's solution and lactate ringer's solution on early postoperative renal function and prognosis in patients with traumatic brain injury (TBI). DESIGN: A single-center, randomized, parallel controlled clinical study. SETTING: General Hospital of Northern Theater Command. PATIENTS: We recruited 124 TBI patients and intended to conduct emergency open craniocerebral surgery from June 2025 to December 2025. INTERVENTIONS: Patients were randomly assigned to two groups (n = 62 each): SBRS group and LRS group (administer fluid replacement with Sodium bicarbonate ringer's solution. and Lactated ringer's solution respectively). MEASUREMENTS: ), oxygenation index (OI), and base excess (BE) at the time of entering the operating room (T0), after induction (T1),at the end of surgery (T2),at 12 h after the end of surgery (T3).Clinical outcome assessment included duration of mechanical ventilation,length of ICU stay,total length of hospital stay,incidence of acute kidney injury (AKI),improvement rate of short-term prognosis. MAIN RESULTS: in the LRS group (3.58 ± 0.52 mmol/L) was significantly higher than that in the SBRS group (3.52 ± 0.50 mmol/L), with least squares mean differences of 0.14 (95% CI: 0.04, 0.24; P = 0.011).Other outcomes didn't show statistical differences. CONCLUSIONS: Compared with Lactated ringer's solution, Sodium bicarbonate ringer's solution used for perioperative fluid therapy in patients with TBI can better promote the early recovery of postoperative renal function, and this solution can significantly reduce blood lactate levels,yet this advantage does not translate into a significant impact on patients' postoperative clinical outcomes. This study therefore provides new evidence for fluid selection in perioperative volume therapy for TBI patients, however, the level of supporting evidence is limited, and further research in larger-scale multicenter trials is warranted. TRIAL REGISTRATION: www.chictr.org.cn (Registration number ChiCTR2500102850, Registration date May 21, 2025).
Hui et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: